Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Income Statement [Abstract]    
Revenues $ 0 $ 0
Costs and Expenses    
Operating expenses 2,103,000 2,915,000
Research and development expenses 279,000 578,000
Loss before other income (expense) (2,382,000) (3,493,000)
Other income 2,000 11,000
Interest and financing expense (1,617,000) (747,000)
Loss on disposition of equipment (3,000) 0
Net loss $ (4,000,000) $ (4,229,000)
Net loss per common share, basic and diluted $ (0.02) $ (0.02)
Weighted average common shares outstanding, basic and diluted 192,831,810 182,267,719